|
|
|
English articles
Vol. 12 / 2011
№ art. | Pages | Title / autors |
January |
1 |
1-11 |
|
2 |
12-20 |
|
3 |
21-31 |
|
4 |
32-40 |
|
5 |
41-49 |
|
6 |
50-68 |
|
7 |
69-81 |
|
8 |
82-92 |
|
9 |
93-104 |
|
10 |
105-128 |
|
11 |
129-142 |
|
12 |
143-160 |
|
13 |
161-177 |
|
14 |
178-183 |
|
15 |
179-184 |
|
February |
16 |
185-201 |
|
17 |
202-217 |
|
18 |
218-227 |
|
19 |
228-237 |
|
20 |
238-246 |
|
21 |
247-252 |
|
22 |
253-260 |
|
March |
23 |
261-289 |
|
24 |
290-300 |
|
25 |
301-310 |
|
26 |
311-325 |
|
27 |
326-333 |
|
28 |
334-342 |
|
April |
29 |
343-352 |
|
30 |
353-363 |
|
31 |
364-373 |
|
Jun |
41 |
483-494 |
Investigation of the motor-evacuation fenction of the gastrointestinal tract in patients with complicated colorectal cancer.
A.M. Belayev, V.M. Luft, O.V. Babkov, A.A. Zacharenko, D.A. Surov, A.A. Domanskii, O.A.Ten, A.A. Trushin, S.A. Kondratsov, D.A. Rudakov, S.A. Ivanitskii, A.V. Lapitskii
|
42 |
495-510 |
|
43 |
511-521 |
|
44 |
522-535 |
|
45 |
536-545 |
|
46 |
546-557 |
|
47 |
558-571 |
|
48 |
572-587 |
|
49 |
588-597 |
|
50 |
598-609 |
|
51 |
610-619 |
|
52 |
620-630 |
|
53 |
631-645 |
|
54 |
646-664 |
|
55 |
665-678 |
|
56 |
679-689 |
|
July |
57 |
690-700 |
|
58 |
701-710 |
|
59 |
711-723 |
|
60 |
724-732 |
|
61 |
733-739 |
|
62 |
740-746 |
|
August |
63 |
747-762 |
|
64 |
763-780 |
The treatment of relapsed/refractory multiple myeloma
S.S. Bessmeltsev, L.V. Stelmashenko, E.V. Kariagina, G.N. Salogub, T.L. Shelkovskya, T.A. Malachova, I.A. Skorochod, N.V. Medvedeva, N.O. Saraeva, K.M. Abdulkadyrov, L.I. Krilova, E.V. Romanova, A.V. Sherbakova, I.I. Kostroma, E.R. Machulaitene, N.A. Kotova, O.I. Kovalev, I.A. Novokreshenova, O.Ya. Khostina, M.A. Novikova
|
65 |
781-793 |
|
66 |
794-802 |
|
67 |
803-810 |
|
68 |
811-816 |
|
69 |
817-824 |
|
70 |
825-846 |
|
71 |
847-863 |
|
72 |
864-872 |
|
September |
73 |
873-886 |
|
74 |
887-899 |
|
75 |
900-909 |
|
76 |
910-923 |
|
77 |
924-935 |
|
78 |
936-947 |
|
79 |
948-958 |
|
80 |
959-979 |
|
81 |
980-989 |
|
82 |
990-1013 |
|
October |
83 |
1014-1029 |
|
84 |
1030-1040 |
|
85 |
1041-1047 |
|
86 |
1048-1066 |
|
87 |
1067-1091 |
|
88 |
1092-1100 |
|
89 |
1101-1118 |
|
90 |
1119-1126 |
|
91 |
1127-1133 |
|
92 |
1134-1146 |
|
93 |
1147-1155 |
|
94 |
1156-1168 |
|
95 |
1169-1179 |
|
96 |
1180-1196 |
|
November |
97 |
1197-1206 |
|
98 |
1207-1216 |
|
99 |
1217-1226 |
|
100 |
1227-1234 |
|
101 |
1235-1247 |
|
December |
102 |
1248-1265 |
|
103 |
1266-1277 |
|
104 |
1278-1297 |
|
105 |
1298-1310 |
|
106 |
1311-1319 |
|
107 |
1320-1328 |
|
108 |
1329-1341 |
BRCA1, CHEK2, NBS1, CFTR, PAH and СX26 founder mutations in healthy female residents of St. Petersburg
N.Y. Tсybakova1,2, A.P. Sokolenko1,3, A.G. Iyevleva1,3, E.N. Suspitsin1,3, E.N. Imyanitov1,3,4.
|
109 |
1342-1349 |
|
110 |
1350-1360 |
|
111 |
1361-1371 |
|
112 |
1372-1380 |
|
113 |
1381-1393 |
|
114 |
1394-1399 |
|
115 |
1400-1410 |
|
116 |
1411-1422 |
|
117 |
1423-1436 |
|
118 |
1437-1449 |
|
119 |
1450-1466 |
|
120 |
1467-1477 |
|
121 |
1478-1486 |
|
|